Comparison of clinical therapeutic effect between Sanjiezhentong capsule per oral and Mifepristone in treatment of endometriosis after laparoscopic conservative surgery
LU Mei-y
Abstract
LU Mei-y
Abstract
Objective:To compare the therapeutic efficacy of Sanjiezhentong capsule and Mifepristone for endometriosis after laparoscopic conservative surgery.Methods:A retrospective analysis was made in 51 patients with endometriosis who accepted laparoscopic surgery from Sep.2006 to Jun.2008.29 cases underwent treatment of Sanjiezhentong capsule after surgery and 22 cases received Mifepristone.Results:The total effective rate of Sanjiezhentong capsule group was 72.4% and 72.7% in Mifepristone group,the difference was not significant(P0.05).Moreover the conception rate of sterile patients was 31.3% in Sanjiezhentong group and 30.0% in Mifepristone group,the difference was not significant(P0.05).The difference of the recurrence rate in one year was not significant,27.6% in Sanjiezhentong capsule group and 27.3% in Mifepristone group(P0.05).However,the incidence rate of side-effects in Sanjiezhentong capsule group was less than that in Mifepristone group(P0.05).Conclusions:Sanjiezhentong capsule and Mifepristone are effective adjunctive therapies for patients with endometriosis after laparoscopic operation.But Sanjiezhentong capsule avoids side-effect of Mifepristone,guttate hemorrhage,hepatic and renal lesion,and does not significantly affect endocrine.With normal menstruation,patients would like to take Sanjiezhentong capsule which does not affect normal conception.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare the therapeutic efficacy of Sanjiezhentong capsule and Mifepristone for endometriosis after laparoscopic conservative surgery.Methods:A retrospective analysis was made in 51 patients with endometriosis who accepted laparoscopic surgery from Sep.2006 to Jun.2008.29 cases underwent treatment of Sanjiezhentong capsule after surgery and 22 cases received Mifepristone.Results:The total effective rate of Sanjiezhentong capsule group was 72.4% and 72.7% in Mifepristone group,the difference was not significant(P0.05).Moreover the conception rate of sterile patients was 31.3% in Sanjiezhentong group and 30.0% in Mifepristone group,the difference was not significant(P0.05).The difference of the recurrence rate in one year was not significant,27.6% in Sanjiezhentong capsule group and 27.3% in Mifepristone group(P0.05).However,the incidence rate of side-effects in Sanjiezhentong capsule group was less than that in Mifepristone group(P0.05).Conclusions:Sanjiezhentong capsule and Mifepristone are effective adjunctive therapies for patients with endometriosis after laparoscopic operation.But Sanjiezhentong capsule avoids side-effect of Mifepristone,guttate hemorrhage,hepatic and renal lesion,and does not significantly affect endocrine.With normal menstruation,patients would like to take Sanjiezhentong capsule which does not affect normal conception.
Key concepts: Mifepristone, Medicine, Endometriosis, Capsule, Surgery, Therapeutic effect, Significant difference, Laparoscopy